| # | Drug | Count |
|---|---|---|
| 0 | MITOTANE | 24 |
| 1 | CISPLATIN | 22 |
| 2 | ETOPOSIDE | 21 |
| 3 | DOXORUBICIN | 17 |
| 4 | METHOTREXATE SODIUM | 14 |
| 5 | METHOTREXATE | 13 |
| 6 | AMLODIPINE | 8 |
| 7 | RAMIPRIL | 7 |
| 8 | DOXAZOSIN MESYLATE | 6 |
| 9 | ANTI ITCH | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MITOTANE | 24 | 0.0131 |
| 1 | PURIXAN | 1 | 0.0013 |
| 2 | METYRAPONE | 1 | 0.0010 |
| 3 | MIFEPRISTONE | 3 | 0.0006 |
| 4 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 2 | 0.0004 |
| 5 | LOMUSTINE | 1 | 0.0004 |
| 6 | CEVIMELINE HYDROCHLORIDE | 1 | 0.0004 |
| 7 | VINORELBINE | 2 | 0.0003 |
| 8 | ETOPOSIDE | 21 | 0.0003 |
| 9 | CISPLATIN | 22 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenal Steroid Synthesis Inhibitor [EPC] | 1 | 0.0010 |
| 1 | Progestin Antagonist [EPC] | 3 | 0.0006 |
| 2 | Topoisomerase Inhibitor [EPC] | 21 | 0.0003 |
| 3 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |
| 4 | Platinum-based Drug [EPC] | 25 | 0.0001 |
| 5 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 1 | 0.0001 |
| 6 | Angiotensin Converting Enzyme Inhibitor [EPC] | 7 | 0.0001 |
| 7 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Phenothiazine [EPC] | 1 | 0.0000 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 13 | 0.0000 |